Skip to main content
RxCopaysGet started

Lennox-Gastaut Syndrome

Rare

Neurological

Lennox-Gastaut Syndrome is treated with 4 medications in our database, including CLONAZEPAM, HYMPAVZI, Fintepla, LAMICTAL, LAMICTAL ODT. 3 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Roche, Pfizer, UCB, GlaxoSmithKline. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Lennox-Gastaut Syndrome treatment below.

What help exists for Lennox-Gastaut Syndrome

20

drugs indexed

13

with copay cards

14

with patient assistance

22

open travel grants

Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.

Drugs used to treat Lennox-Gastaut Syndrome

20 total

🎟 = copay card · 💙 = patient assistance program

Prior authorization patterns for Lennox-Gastaut Syndrome drugs

Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.

PayerPAStep therapyCopay tier

—

Medicare Part D

———

—

Medicare Part D

———

—

Medicare Part D

———

—

Medicare Part D

———

—

Medicare Part D

———

—

Medicare Part D

———

—

Medicare Part D

———

—

Medicare Part D

———

—

Medicare Part D

———

—

Medicare Part D

———

Showing 10 of 25 PA rules for Lennox-Gastaut Syndrome drugs. View individual drug pages for complete PA detail.

Grants for Lennox-Gastaut Syndrome patients

30 total · 22 open

Lennox-Gastaut Syndrome is a rare disease — more resources at UniteRare

Our sister site covers specialists, clinical trials, patient communities, and rare-disease-specific diagnosis tools.

Visit UniteRare →